Диссертация (Роль иммунно-воспалительных изменений в оценке алкогольного поражения печени. Торасемид sr в лечении отечно-асцитического синдрома при циррозе печени), страница 20

2009 Jun27;373(9682):2223-2233.199. Reiberger T., Ferlitsch A., Payer B.A., Mandorfer M., Heinisch B.B., Hayden H.,Lammert F., Trauner M., Peck-Radosavljevic M., Vogelsang H. Non-selectivebetablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6in patients with cirrhosis. J. Hepatol. 2013, 58, 911–921.200. Roulot D., Czernichow S., Le Clésiau H., Costes J.-L., Vergnaud A.-C., BeaugrandM. Liver stiffness values in apparently healthy subjects: Influence of gender andmetabolic syndrome // J Hepatol.

2008;48:606–613.201. Roulot D. Transient elastography as a screening tool for liver fibrosis and cirrhosisin a community-based population aged over 45 years / Roulot D., Costes JL, Buyck JF,Warzocha U, Gambier N, Czernichow S, Le Clesiau H, Beaugrand M. // Gut. 2011 Jul;60(7):977-84.109202. Sagir A., Erhardt A., Schmitt M., Häussinger D. Transient elastography isunreliable for detection of cirrhosis in patients with acute liver damage // Hepatology.2008 Feb;47(2):592-595.203. Sandford N.L., Walsh P., Matis C. et al. Is ultrasonography useful in the liverassessment of diffuse parenchymal liver disease? // Gastroenterology 1985;89:186-191.204.

Sandrin L. Transient elastography: a new non-invasive method for assessment ofhepatic fibrosis / Sandrin L., Fourquet B., Hasquenoph J.M. // Ultrasound Med Biol2003;29:1705–1713.205. Sato M. Hepatic stellate cells: unique characteristics in cell biology and phenotype/ Sato M., Suzuki S., Senoo H. // Cell Struct Funct 2003; 28: 105–12.206. Schiavon L., Narciso-Schiavon J., de CarvalhoFilho R. J.

Non-invasive diagnosisof liver fibrosis in chronic hepatitis C. World J Gastroenterol 2014; 20(11):2854-66.207. Schiff ER, Heathcote EJ, Dienstag JL, Hann H-W, Woessner M, Brown NA. et al.Improvements in liver histology and cirrhosis with extended lamivudin therapy(abstract). Hepatology 2000; 32: 296a.208. Sebastiani et al., SAFE biopsy: a validated method for large-scale staging of liverfibroses in chronic hepatitis C // Hepatology 2009;49:1821.209. Shaheen A.A.

Diagnostic accuracy of the aspartate aminotransferase-to-plateletratio index for the prediction of hepatitis C-related fibrosis: a systematic review /Shaheen A.A., Myers R.P. // Hepatology 2007;46:912–921.210. Sharma S et al . Non-invasive diagnosis of cirrhosis. World J Gastroenterol 2014December 7; 20(45): 16820-16830.211. Shiratori Y, Imazeki F, Moriyama M, Yano M, Arakawa Y, Yokosuka O. et al.Histologic improvement of fibrosis in patients with hepatitis C who have sustainedresponse to interferon therapy.

Ann Intern Med. 2000; 132: 517–24.110212. Soresi M. Non invasive tools for the diagnosis of liver cirrhosis / Soresi M.,Giannitrapani L., Cervello M., Licata A., Montalto G. // World J Gastroenterol 2014December 28; 20(48): 18131-18150.213. Talley NJ, Roth A, Woods J, Hench V. Diagnostic value of liver biopsy in alcoholicliver disease // J Clin Gastroenterol 1988; 10: 647–50.214. Tobkes AI, Nord HJ.

Liver biopsy: review of methodology and complication.Digetion. 1995;13:267.215. Tran A., Hastier P., Barjoan E.M. et al. Non invasive prediction of severe fibrosisin patients alcoholic liver disease // Gastroenterol Clin Biol. 2000. - №24. - P.626-630.216. Tung K.H., Huang Y.S., Yang K.C., Perng, C.L., Lin H.C., Lee S.D. Seruminterleukin-12 levels in alcoholic liver disease. J. Chin.

Med. Assoc. 2010, 73, 67–71.217. Vergniol J. Noninvasive tests for fibrosis and liver stiffness predict 5-yearoutcomes of patients with chronic hepatitis C / Vergniol J., Foucher J., Terrebonne E.,Bernard P.H., Bail B., Merrouche W., et al. // Gastroenterology 2011;140:1970–1979.218.

Vizzutti F. Elastography for the non-invasive assessment of liver disease:limitations and future developments / Vizzutti F., Arena U., Marra F., et al. // Gut.2009;58:157-160.219. WHO, European Status Report on Alcohol and Health 2010. Copenhagen: WHORegional Office for Europe; 2010.220. Wong G.L. Clinical factors associated with liver stiffness in hepatitis B e antigenpositive chronic hepatitis B patients / Wong G.L., Wong V.W., Choi P.C., et al.

// ClinGastroenterol Hepatol 2009;7:227-233.221. Wong V.W. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement innonalcoholic fatty liver disease / Wong V.W., Vergniol J., Wong G.L., et al. //Hepatology 2009;51:454-462.111222. Wong V.W. Transient elastography / Wong V.W., Chan H.L. // J GastroenterolHepatol 2010; 25: 1726-1731.223. Wynn T.A. Cellular and molecular mechanisms of fibrosis // J. Pathol. 2008; 214:199-210.224. Wu J., Zern M.A.

Hepatic stellate cells: a target for the treatment of liver fibrosis //J Gastroenterol. 2000. - 35 (9). - P.665-672.225. Yang L, Froio RM, Sciuto TE, Dvorak AM, Alon R, Luscinskas FW ICAM-1regulates neutrophil adhesion and transcellular migration of TNF-alpha-activatedvascular endothelium under flow. Blood, 2005 106 (2): 584–592.226. Yin M., Talwalkar J.A., Glaser K.J., et al. Assessment of hepatic fibrosis withmagnetic resonance elastography // Clin Gastroenterol Hepatol. 2007 Oct;5(10):12071213.227. Yip WW.

Alcoholic liver disease / Yip W.W. // Semin Diagn Pathol 2007; 23:149–60.228. Zago P., Moreira F.P, Jansen K., Lhullier A. C, da Silva R. A, et al. (2016) AlcoholUse Disorder and Inflammatory Cytokines in a Population Sample of Young Adults. JAlcohol Drug Depend 4: 236.229.

Zhou W.-C. Pathogenesis of liver cirrhosis / Zhou W.-C., Zhang Q.-B., Qiao L. //World J. Gastroenterol. – 2014. – v. 20. – p. 7312-7324.230. Ziol M. Non-invasive assessment of liver fibrosis by stiffness measurement: aprospective multicentre study in patients with chronic hepatitis С / Ziol M., HandraLuca A., Kettaneh A. et al. // Hepatology. — 2005. — Vol. 41, № 1. — P.

48-54.231. Yang L, Froio RM, Sciuto TE, Dvorak AM, Alon R, Luscinskas FW ICAM-1regulates neutrophil adhesion and transcellular migration of TNF-alpha-activatedvascular endothelium under flow. Blood, 2005 106 (2): 584–592..